SCHEMBL24300098

SCHEMBL24300098

NC(O)c1nc(F)cnc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28899475 0.70
SCHEMBL25028569 0.64
Favipiravir SCHEMBL587913 0.64 LCK (0.34)
Favipiravir SCHEMBL30725561 0.63 LCK (0.33)
Favipiravir SCHEMBL21085196 0.63 LCK (0.33)
SCHEMBL28398570 0.61 KDM4E (0.37)
SCHEMBL23677299 0.61
SCHEMBL31259490 0.60 PLAU (0.33)
SCHEMBL29622124 0.59
SCHEMBL7893014 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022066798-A1 INTERFERON TAU FC-FUSION PROTEINS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS SOUTHLAKE PHARMACEUTICALS, INC. (US) 2022-03-31 WO disclosed